NPS RADAR March 2010NPS RADAR March 2010

NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.

Find out more about NPS RADAR.



Title Why read this
Nebivolol (Nebilet) for chronic heart failure Professional publication - NPS RADAR - Review Nebivolol is an alternative to bisoprolol, carvedilol, and controlled-release metoprolol but has less robust evidence of survival benefit.
Methylnaltrexone injection (Relistor) for opioid-induced constipation in palliative care Professional publication - NPS RADAR - Review Methylnaltrexone is an option for treating opioid-induced constipation in people receiving palliative care who have not responded to adequately titrated laxatives. About half of these people will have a bowel movement within 4 hours of a single dose.
Authority listing for terbinafine extended to children and adolescents Professional publication - NPS RADAR - Brief item Authority listing for terbinafine extended to children and adolescents.
Albendazole (Zentel) listing extended to treat hookworm and strongyloidiasis Professional publication - NPS RADAR - Brief item Strongyloidiasis and hookworm are common in tropical regions including Aboriginal and Torres Strait Islander communities in northern Australia. Albendazole is the treatment of choice for hookworm. Ivermectin is first choice for strongyloidiasis but albendazole is an alternative for those in whom ivermectin is unsuitable.

Complete list of all NPS RADAR content.

Find out more about NPS RADAR.

Date published: 2010-03-01 00:00:00

Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.

References to brands should not be taken as an endorsement by NPS.